Works matching DE "PROGRAMMED death-ligand 1"

Results: 3894

Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2199, doi. 10.3390/cancers17132199

By:

Khalil, Maryam;
Tsao, Ming-Sound

Publication type:

Article

The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2190, doi. 10.3390/cancers17132190

By:

Marković, Filip;
Hochmair, Maximilian;
Müser, Nino;
Fabikan, Hannah;
Rodriguez, Vania Mikaela;
Janzic, Urska;
Stjepanović, Mihailo;
Kontić, Milica

Publication type:

Article

TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2188, doi. 10.3390/cancers17132188

By:

Brunetti, Leonardo;
Santo, Valentina;
Galletti, Alessandro;
Gelibter, Alain;
Lugini, Antonio;
Spinelli, Gian Paolo;
Santini, Daniele;
Cortellini, Alessio;
Vendittelli, Alessia;
Di Fazio, Giuseppina Rita;
Citarella, Fabrizio;
La Cava, Giulia;
Mingo, Emanuele Claudio;
Fiorenti, Matteo;
Cristofani, Leonardo;
Mariotti, Sabrina;
Ricciardi, Serena;
Pantano, Francesco;
Vincenzi, Bruno;
Tonini, Giuseppe

Publication type:

Article

Dysregulated miRNA Expression and Its Association with Immune Checkpoints in Head and Neck Cancer.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2169, doi. 10.3390/cancers17132169

By:

Shuaib, Mohd;
Saini, Diksha;
Sharma, Gargi;
Singh, Ishwar;
Gupta, Sanjay;
Kumar, Shashank;
Kumar, Pramod

Publication type:

Article

Immune Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2125, doi. 10.3390/cancers17132125

By:

Gilson, Alice;
Tan, Vincent;
Koessler, Thibaud;
Meyer, Jeremy;
Meurette, Guillaume;
Liot, Émilie;
Ris, Frédéric;
Delaune, Vaihere

Publication type:

Article

Subclassification-Specific Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Implications for Appropriate Pharmacotherapy.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2082, doi. 10.3390/cancers17132082

By:

Kinoshita, Masahiko;
Sato, Yasunori;
Kubo, Shoji;
Shinkawa, Hiroji;
Kimura, Kenjiro;
Nishio, Kohei;
Tanaka, Ryota;
Kurihara, Shigeaki;
Ishizawa, Takeaki

Publication type:

Article

Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive Review.

Published in:

Molecules, 2025, v. 30, n. 13, p. 2686, doi. 10.3390/molecules30132686

By:

Kciuk, Mateusz;
Wanke, Katarzyna;
Kruczkowska, Weronika;
Marciniak, Beata;
Kontek, Renata

Publication type:

Article

PD-L1 Expression and Comprehensive Genomic Profiling in Advanced NSCLC: A Single-Centre Experience.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6348, doi. 10.3390/ijms26136348

By:

Gurevičienė, Giedrė;
Poškienė, Lina;
Miliauskas, Skaidrius;
Žemaitis, Marius

Publication type:

Article

Full-Length Transcriptome Sequencing Reveals Treg-Specific Isoform Expression upon Activation.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6302, doi. 10.3390/ijms26136302

By:

Sato, Yohei;
Osada, Erika;
Manome, Yoshinobu

Publication type:

Article

PD-L1 Expression in NSCLC: Clouds in a Bright Sky.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6066, doi. 10.3390/ijms26136066

By:

Ferrari, Victoria;
Gal, Jocelyn;
Mograbi, Baharia;
Milano, Gerard

Publication type:

Article

PD-L1 expression and its association with clinicopathological and computed tomography features in surgically resected non-small cell lung cancer: a retrospective cohort study.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-10437-9

By:

Wang, Shiwei;
Xu, Mingyue;
Liu, You;
Hou, Xiaoming;
Gao, Zhaofeng;
Sun, Jingjie;
Shen, Leilei

Publication type:

Article

铁死亡相关基因的 DNA 甲基化风险评分模型在结肠癌预后与免疫特征评估中的应用.

Published in:

Practical Oncology Journal, 2025, v. 39, n. 3, p. 224, doi. 10.11904/j.issn.1002-3070.2025.03.008

By:

李冬生;
李泽昊;
陈永刚

Publication type:

Article

Durable immunotherapeutic response in molecularly complex pulmonary adenosquamous carcinoma: case report and literature review.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1614283

By:

Zhu, Jun;
Xun, Xin;
Liu, Jiayun;
Su, Bin;
Li, Yi;
Chen, Hong;
Huang, Meijin

Publication type:

Article

Exploring the impact of diet, sleep, and metabolomic pathways on Glaucoma subtypes: insights from Mendelian randomization and cross-sectional analyses.

Published in:

Nutrition & Metabolism, 2025, v. 22, n. 1, p. 1, doi. 10.1186/s12986-025-00967-4

By:

Shengnan, Zhang;
Tao, Wang;
Yanan, Zhang;
Chao, Sun

Publication type:

Article

Large language models-enabled digital twins for precision medicine in rare gynecological tumors.

Published in:

NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01810-z

By:

Lammert, Jacqueline;
Pfarr, Nicole;
Kuligin, Leonid;
Mathes, Sonja;
Dreyer, Tobias;
Modersohn, Luise;
Metzger, Patrick;
Ferber, Dyke;
Kather, Jakob Nikolas;
Truhn, Daniel;
Adams, Lisa Christine;
Bressem, Keno Kyrill;
Lange, Sebastian;
Schwamborn, Kristina;
Boeker, Martin;
Kiechle, Marion;
Schatz, Ulrich A.;
Bronger, Holger;
Tschochohei, Maximilian

Publication type:

Article

OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1.

Published in:

Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-08433-w

By:

Zhang, Hongchen;
Ling, Min;
Zhang, Yuheng;
Fang, Qing;
Wo, Wanlong;
Lv, Xiaoai

Publication type:

Article

Nomograms for stratified prognosis prediction of gastric cancer by integrating programmed death ligand 1 and tumor-infiltrating immune cells including CD4+/CD8+ TILs and CD163+ TAMs.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1530054

By:

Qi, Xiumin;
Guo, Yixuan;
Xiao, Yan;
Pan, Xiang;
Chen, Fangming;
Zhang, Xu

Publication type:

Article

PD-L1 expression on tumor cells and tumor-infiltrating immune cells in thymic epithelial tumors detected with SP142 and SP263 antibodies.

Published in:

PLoS ONE, 2025, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0327792

By:

Chubachi, Kei;
Tanaka, Hisashi;
Taima, Kageaki;
Tasaka, Sadatomo;
Kurose, Akira

Publication type:

Article

SPTSSA facilitates gastric cancer progression with modulating PD-L1 in immunomicroenvironment through Wnt/β-catenin pathway.

Published in:

Cellular Oncology (2211-3428), 2025, v. 48, n. 4, p. 1127, doi. 10.1007/s13402-025-01072-7

By:

Sun, Pingping;
Qin, Weiwei;
Xu, Haiyan;
Yin, Hang;
Yang, Lei;
Zhang, Xiaojing;
Jin, Xiaoxia;
Xu, Qiang;
Wu, Han;
Kuai, Xiaoling;
Jia, Lizhou;
Huang, Jianfei;
Wang, Yao

Publication type:

Article

Optimal Timing of PD-1/PD-L1 Blockade Protects Organ Function During Sepsis.

Published in:

Inflammation, 2025, v. 48, n. 3, p. 975, doi. 10.1007/s10753-024-02113-3

By:

Xiang, Jing;
Wang, Yuanyang;
Shi, Langtian;
Qiu, Jinchao;
Gan, Lebin;
Xu, Zhe;
Zhang, Huacai;
Deng, Jin;
Wang, Zhen;
Xu, Fang;
Zeng, Ling

Publication type:

Article

Programmed Death Ligand 1 Modulation by Bacillus Calmette-Guérin and Toll-Like Receptor Agonists in Distinct Breast Cancer Cell Subtypes.

Published in:

International Journal of General Medicine, 2025, v. 18, p. 3401, doi. 10.2147/IJGM.S531858

By:

Barbosa, Gabriela;
Godoy, Maria Carolina Ximenes De;
Bighetto, Caroline Cavalli;
Skakum, Emily Macedo;
Pascoal, Lívia Bitencourt;
Gambero, Alessandra;
Reis, Leonardo O

Publication type:

Article

BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1618110

By:

Chen, Jianxin;
Wang, Jian;
Fang, Weiqiang;
Wu, Yating;
Li, Hang;
Xu, Hui;
Zhu, Yunyun;
Cheng, Yanran;
Yu, Zongyang;
Peng, Yonghai

Publication type:

Article

Using 18F-FDG PET/CT to predict programmed cell death ligand expression in non-small cell lung cancer via metabolic tumour heterogeneity.

Published in:

British Journal of Radiology, 2025, v. 98, n. 1169, p. 715, doi. 10.1093/bjr/tqaf034

By:

Chang, Ruxi;
Luo, Liang;
Shen, Cong;
Zhang, Weishan;
Duan, Xiaoyi

Publication type:

Article

PD-L1 Expression and Tumor Microenvironment Dynamics in Diffuse Large B-Cell Lymphoma: Immunophenotypic Insights.

Published in:

Journal of Medicine & Life, 2025, v. 18, n. 5, p. 463, doi. 10.25122/jml-2025-0078

By:

Halcu, Georgian;
Mureșan, Filip Cristian;
Niculae, Andrei;
Evsei-Seceleanu, Anca;
Lapadat, Mihai-Emilian;
Cerbu, Mihai Adrian;
Ceausu, Mihail

Publication type:

Article

Association of the combined parameters including the frequency of primary cilia, PD-L1, Smoothened protein, membranous ß-catenin and cytoplasmic ß-catenin expression with the outcome of patients with clear cell renal cell carcinoma.

Published in:

Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2025, v. 169, n. 2, p. 107, doi. 10.5507/bp.2024.005

By:

Rozsypalova, Aneta;
Rosova, Blanka;
Filipova, Alzbeta;
Nikolov, Dimitar Hadzi;
Chloupkova, Renata;
Richter, Igor;
Zachoval, Roman;
Matej, Radoslav;
Melichar, Bohuslav;
Buchler, Tomas;
Dvorak, Josef

Publication type:

Article

N6-methyladenosine modification of MEF2A weakens cetuximab sensitivity in colorectal cancer via PD-L1/SOX12 axis.

Published in:

Cell Death Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41420-025-02577-8

By:

Gao, Cao;
He, Jiajia;
Zhao, Jiemin;
Ni, Xuefeng;
Xu, Yanjie

Publication type:

Article

Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity.

Published in:

BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04230-8

By:

Shi, Zhuangzhuang;
Jiang, Wenxing;
Li, Hongwen;
Zhang, Yue;
Xue, Weili;
Wang, Yingjun;
Zhang, Mingzhi;
Li, Zhaoming

Publication type:

Article

Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer.

Published in:

BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04198-5

By:

Liu, Jing;
Lan, Chunyan;
Liu, Tongyu;
Liu, Qin;
Chang, Lele;
Zang, Lele;
Zhu, Fei;
Zhu, Mingxuan;
Zhang, Huiqi;
Kang, Yaxin;
Wang, Yuqin;
Lu, Huaiwu;
Sun, Yang;
Xu, Qin

Publication type:

Article

Elucidating the role of N-myristoylation in the excessive membrane localization of PD-L1 in hypoxic cancers and developing a novel NMT1 inhibitor for combination with immune checkpoint blockade therapy.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03438-z

By:

Zhao, Haoming;
Zhang, Zhen;
Zhang, Chaojun;
Ma, Hexin;
Wan, Qingqing;
Zhao, Xinran;
Wang, Xu;
Yan, Ming;
Guo, Haiyan;
Zhang, Jianjun;
Chen, Wantao

Publication type:

Article

Real-World Effectiveness and Safety Profile of Atezolizumab in Small-Cell Lung Cancer Treatment.

Published in:

Indian Journal of Pharmaceutical Sciences, 2025, v. 87, n. 3, p. 108

By:

LOZANO, ROBERTO;
FRANCO, MARIA ESTHER;
BONA, CARINA

Publication type:

Article

Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 9, p. 3211, doi. 10.1007/s00259-025-07201-6

By:

Qin, Jingjie;
Han, Chao;
Li, Haoqian;
Wang, Zhendan;
Hu, Xudong;
Liu, Lanping;
Zhu, Shouhui;
Zhao, Jingjing;
Sun, Yuhong;
Wei, Yuchun

Publication type:

Article

Preclinical and first‑in‑human evaluation of [68Ga]Ga-DOTA-PEG2-Asp2-PDL1P PET imaging to assess tumor PD-L1 expression.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 9, p. 3278, doi. 10.1007/s00259-025-07173-7

By:

Chen, Yang;
Hu, Yinting;
Li, Ao;
Zhang, Guojin;
Guo, Danyi;
Yao, Xinchao;
Zeng, Baozhen;
Tang, Ganghua;
Jiang, Benyuan;
Jiang, Lei

Publication type:

Article

Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14482-5

By:

Ansab, Muhammad;
Razi, Sepideh;
Nisa, Farwa;
Araib, Eiman;
Rath, Shree;
Khan, Iqra;
Ramzan, Noor Ul Huda;
Dilawar, Esha;
Saeed, Anwaar

Publication type:

Article

Efficacy and safety outcomes of PD-1/PD-L1 inhibitors in recurrent cholangiocarcinoma: a real-world, multicenter and retrospective study.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14459-4

By:

Lin, Lihui;
Lin, Yansong;
Chen, Wei;
Yang, Xia;
Guo, Xianwen;
Wu, Yanqin;
Yin, Xiaoyu;
Ding, Zhen;
Yun, Jingping

Publication type:

Article

De Novo Design of Structure‐Tunable Multivalent Targeting Chimeras for Tumor‐Targeted PD‐L1 Degradation and Potentiated Cancer Immunotherapy.

Published in:

Angewandte Chemie, 2025, v. 137, n. 27, p. 1, doi. 10.1002/ange.202504233

By:

Zhou, Huiling;
Hou, Bo;
Shan, Yiming;
Huang, Lujia;
Chen, Fangmin;
Ren, Siyuan;
Zhang, Shunan;
Pan, Jiaxing;
Dang, Yijing;
Yu, Haijun;
Xu, Zhiai

Publication type:

Article

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Published in:

Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192

By:

Hatanaka, Takeshi;
Yata, Yutaka;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Kakizaki, Satoru;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Koshiyama, Yuichi;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi

Publication type:

Article

Deciphering cardiotoxicity in PD-1/PD-L1 inhibitor treatment.

Published in:

Central European Journal of Immunology, 2025, v. 50, n. 1, p. 2, doi. 10.5114/ceji.2025.151335

By:

Tabarkiewicz, Jacek;
Głodkowska-Mrówka, Eliza;
Eljaszewicz, Andrzej

Publication type:

Article

The Versatile Role of Period Circadian Regulators (PERs) in Oral Squamous Cell Carcinoma.

Published in:

Biocell, 2025, v. 49, n. 6, p. 961, doi. 10.32604/biocell.2025.062918

By:

Huang, Mei;
Zhang, Zhenyu;
Luo, Yuqi;
Wu, Yuqi;
Pan, Dan;
Zhou, Yu;
Luo, Xiaobo;
Jiang, Yuchen

Publication type:

Article

Artificial Intelligence (AI) for Programmed Death Ligand-1 (PD-L1) Immunohistochemical Assessment in Urothelial Carcinomas: "Teaching" Cell Differentiation to AI Systems.

Published in:

Life (2075-1729), 2025, v. 15, n. 6, p. 839, doi. 10.3390/life15060839

By:

Nechifor-Boilă, Ioan Alin;
Nechifor-Boilă, Adela;
Loghin, Andrada;
Mihu, Carmen Mihaela;
Melincovici, Carmen Stanca;
Onofrei, Mădălin Mihai;
Chibelean, Călin Bogdan;
Martha, Orsolya;
Borda, Angela

Publication type:

Article

Toripalimab treatment of bladder-preserving therapy for locally advanced bladder cancer: a case report.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1581452

By:

Yang, Zhiyun;
Liu, Yidao;
Li, Ji;
Wang, Xingsheng;
Pan, Jun;
Jiang, Jiafu;
Zhang, Xingming

Publication type:

Article

PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1561942

By:

Tao, Chao;
Liu, Bingyao;
Dai, Yan;
Lv, Jinyi;
He, Huanhuan;
Ding, Qian;
Chen, Kun;
Wang, Ke;
Yang, Liuxuan;
Ren, Xiaoqun;
Zhou, Meiling

Publication type:

Article

Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancer.

Published in:

Oncology Research, 2025, v. 33, n. 7, p. 1633, doi. 10.32604/or.2025.061637

By:

CHENG, CHENG;
SHI, CHAO;
WU, SHANG;
WU, WEIXING;
LI, JINGPING;
GAO, SINUO;
HAN, MENG;
WANG, YIMIN;
ZHANG, XIANGMEI;
LIU, YUNJIANG

Publication type:

Article

High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 12, p. 5592, doi. 10.3390/ijms26125592

By:

Miljak, Antonija;
Pavlović, Antonia;
Benzon, Benjamin;
Čutura, Lučana Vicelić;
Galušić, Davor;
Vujčić, Milan;
Blaslov, Viktor;
Durdov, Merica Glavina

Publication type:

Article

The role of tumor-associated macrophages and PD-1/PD-L1 networking in colorectal cancer.

Published in:

Contemporary Oncology / Współczesna Onkologia, 2025, v. 29, n. 2, p. 123, doi. 10.5114/wo.2025.150448

By:

Yerolatsite, Melina;
Torounidou, Nanteznta;
Amylidi, Anna-Lea;
Zarkavelis, George;
Hadjigeorgiou, Loizos;
Lampri, Evangeli;
Bali, Christina;
Georvasili, Vaia;
Kampletsas, Eleftherios;
Mauri, Davide

Publication type:

Article

Aurantio-obtusin modulates Wilms Tumour 1 within the breast tumour microenvironment reducing immunosuppression and tumour growth.

Published in:

Cell Communication & Signaling, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12964-025-02292-y

By:

Li, Rui;
O'Connor, Dómhnall J;
Digby, Barry;
Broin, Pilib Ó.;
Hu, Xiao;
Ge, Ning;
Loftus, Paul G.;
Kumar, Vatsal;
McEvoy, Eoin;
Elliman, Stephen J.;
Kerin, Michael J.;
Barkley, Laura R.

Publication type:

Article

The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325349

By:

Kong, Dehua;
Gao, Chunyan;
Yu, Yang;
Yang, Lu;
Ma, Ji;
Tang, Shimin;
Mao, Ying;
Li, Yong;
Li, Na

Publication type:

Article

δ‐Tocotrienol Potentiates Breast and Prostate Cancer Cells to Paclitaxel via Suppressing PD‐L1‐Mediated Cancer‐Promoting Signaling.

Published in:

Chemical Biology & Drug Design, 2025, v. 105, n. 6, p. 1, doi. 10.1111/cbdd.70143

By:

Sun, Zhenou;
Ma, Xuan;
Li, Jiaxuan;
Fan, Lihong;
Zhao, Chong;
Yin, Shutao;
Hu, Hongbo

Publication type:

Article

Cosibelimab.

Published in:: American Journal of Health-System Pharmacy, 2025, v. 82, n. 13, p. 638, doi. 10.1093/ajhp/zxaf055
Publication type:: Article

Recent Advances of Shikonin in the Molecular Mechanisms of Anticancer, Anti-Inflammation and Immunoregulation.

Published in:

American Journal of Chinese Medicine, 2025, v. 53, n. 4, p. 1093, doi. 10.1142/S0192415X25500417

By:

Ye, Xiaoyun;
Wu, Xiaohong;
Lian, Siheng;
Cai, Ruina;
Wei, Xianni;
Nan, Tingting;
Cai, Yumei;
Su, Yonglong;
Wei, Jinbao

Publication type:

Article

Synthesis and In Vitro Evaluation of a Scandium-44 Radiolabeled Nanobody as a PD-L1 PET Imaging Probe.

Published in:

Pharmaceutics, 2025, v. 17, n. 6, p. 796, doi. 10.3390/pharmaceutics17060796

By:

Krol, Viktoria E.;
Bansal, Aditya;
Kethamreddy, Manasa;
Ellinghuysen, Jason R.;
Vail, Daniel J.;
Lucien-Matteoni, Fabrice;
Dong, Haidong;
Park, Sean S.;
Pandey, Mukesh K.

Publication type:

Article